Pralidoxime Chloride: Uses, Dosage, Side Effects | MedexInfo
Pralidoxime Chloride
Rx Only
Generic NamePralidoxime Chloride
Therapeutic ClassCholinesterase Reactivator / Antidote
Common Dose1–2 g IV initially
Max / 24hAs clinically indicated
PregnancyCategory C
Indications ▼
Organophosphate insecticide poisoning
Nerve agent exposure
Carbamate poisoning (selected cases)
Adjunct to atropine therapy in cholinergic crisis
Mechanism & Pharmacokinetics ▼
Mechanism: Reactivates acetylcholinesterase inhibited by organophosphates by cleaving the phosphate-enzyme bond, restoring neuromuscular transmission and reducing cholinergic toxicity.
Pharmacokinetics: Administered IV or IM; widely distributed in extracellular fluid. Limited penetration into CNS. Eliminated mainly via kidneys. Half-life approximately 1–2 hours.
Dosage & Administration ▼
| Patient Category | Recommended Dose | Max / 24h |
|---|---|---|
| Adults (Initial) | 1–2 g IV over 15–30 minutes | As clinically required |
| Adults (Maintenance) | 500 mg/hour IV infusion or repeat 1 g every 1 hour as needed | As clinically required |
| Children | 20–50 mg/kg IV over 15–30 minutes | As prescribed |
| IM (Auto-injector) | 600 mg IM; may repeat at 15-minute intervals if needed | As directed |
Note: Administer as soon as possible after exposure. Always use in combination with atropine and supportive care. Adjust dose in renal impairment.
Side Effects ▼
Common: Headache, dizziness, blurred vision
Occasional: Tachycardia, hypertension, nausea
Rare: Muscle rigidity, respiratory distress, hypersensitivity reactions
Contraindications ▼
Known hypersensitivity to pralidoxime
Use cautiously in renal impairment
Drug Interaction ▼
Atropine: used concomitantly for optimal effect
Morphine or CNS depressants: may worsen respiratory depression
Barbiturates: increased neuromuscular weakness risk
Pregnancy & Lactation ▼
Category C; use if benefits outweigh potential risks
Safety in breastfeeding not well established
Clinical / Research Summary ▼
Essential antidote in organophosphate poisoning management.
Most effective when administered early before enzyme “aging” occurs.
Reduces neuromuscular paralysis and respiratory complications.
Patient Counseling Points ▼
Used only in emergency settings under medical supervision.
Immediate medical care required after suspected poisoning.
Report breathing difficulty or severe weakness promptly.
Storage & Handling ▼
Store at 20–25°C; protect from light
Do not use if solution is discolored
Brand Names (Bangladesh & Global) ▼
Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider.